Bedford, Mass., Dec. 08, 2021 (GLOBE NEWSWIRE) — Massachusetts-based biotech Conagen announced its participation in a collaboration supporting the ReSource program funded by a U.S. Department of Defense (DOD) grant. The project aims to leverage Conagen’s proprietary fermentation technology to convert plastics and other energy-dense waste into valuable, reusable materials.

GHENT, Belgium, Dec. 08, 2021 (GLOBE NEWSWIRE) — MRM Health, a clinical-stage biopharmaceutical company developing next-generation live microbiome consortia therapeutics, announced that the first patient received MH002 in a phase 1b/2a multi-center clinical trial in mild-to-moderate Ulcerative Colitis. MH002 is MRM Health’s first clinical product candidate resulting from its proprietary

End of year statistics from JOOR illustrate that online B2B shopping is the new normal; highlight the importance of small business and increasing APAC adoption NEW YORK, Dec. 08, 2021 (GLOBE NEWSWIRE) — JOOR, the world’s leading digital wholesale platform, today released its end of year figures for 2021. These

Investing with intent becoming as clear a priority as financial performance Colliers 2022 Global Investor Outlook LONDON and TORONTO, Dec. 08, 2021 (GLOBE NEWSWIRE) — Leading diversified professional services and investment management company Colliers (NASDAQ and TSX: CIGI) reveals quality office assets in major metropolitan markets like London, New York,

Umicore and Volkswagen AG to create European EV battery materials Joint Venture Umicore and Volkswagen AG plan to establish a joint venture to build up precursor and cathode material production capacities in Europe to supply Volkswagen AG’s European battery cell production, making a considerable contribution to the region’s transition towards